Anticoccidial Drugs Market To Reach $2.91 Billion by 2035

Anticoccidial drugs market was valued at $1.90 billion in 2025 and is projected to reach $2.91 billion by 2035, growing at a CAGR of 4.35% during the forecast period (2026–2035). The increasing global demand for animal protein and the rapid expansion of intensive livestock farming are key macro drivers supporting market growth. According to the Food and Agriculture Organization (FAO), global poultry meat production surpassed 137 million tonnes in 2023, reflecting strong and sustained growth in commercial poultry farming worldwide. This growth is primarily driven by rising population levels, increasing urbanization, and changing dietary preferences toward affordable and high-protein food sources such as poultry and dairy products. In emerging economies, particularly across Asia-Pacific and Latin America, rising disposable incomes are further accelerating the consumption of animal-based protein. As livestock production systems become more intensive to meet this growing demand, the risk of infectious diseases such as coccidiosis increases significantly due to high stocking densities and confined rearing environments. Anticoccidial drugs play a critical role in preventing and controlling these infections, which can otherwise lead to severe intestinal damage, reduced feed efficiency, and increased mortality rates in poultry and livestock. Effective disease management is essential for maintaining productivity, ensuring animal welfare, and minimizing economic losses for farmers.

Browse the full report description of “Anticoccidial Drugs Market Size, Share & Trends Analysis Report, By Drug Class (Ionophores, Chemical Anticoccidials), By Animal Type (Poultry, Livestock, Companion Animals), By End-User (Commercial Poultry Farms, Livestock Farms, Veterinary Clinics & Hospitals, Pet Owners), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/anticoccidial-drugs-market

Growing Livestock Production Supporting Market Growth

The expansion of livestock farming is significantly influencing demand for anticoccidial drugs. According to the Organisation for Economic Co-operation and Development (OECD), global meat consumption is expected to increase by 14% by 2030, driven by population growth and rising income levels. Poultry remains one of the fastest-growing protein sources due to its affordability and shorter production cycles. Anticoccidial drugs are widely used in feed and water treatments to control parasitic infections in intensive farming environments, thereby improving animal health and productivity.

Rising Veterinary Healthcare Investments Driving Adoption
Increasing investments in veterinary healthcare infrastructure are creating strong opportunities for the anticoccidial drugs market. According to the World Organisation for Animal Health (WOAH), improving animal health systems is essential for ensuring global food security and sustainable livestock production. Veterinary clinics and hospitals are increasingly adopting advanced antiparasitic treatments to prevent disease outbreaks in both livestock and companion animals. Growing awareness regarding animal health and zoonotic disease prevention is further supporting the demand for anticoccidial drugs globally.

Key Leaders Transforming the Anticoccidial Drugs Market

The key players in the anticoccidial drugs market include Elanco Animal Health, Zoetis Inc., Huvepharma, Phibro Animal Health Corporation, and Ceva Santé Animale, among others. These companies are focusing on product innovation, strategic partnerships, and geographic expansion to strengthen their market position.

• In October 2025, Phibro Animal Health Corporation announced the national launch of Restoris™ piezoelectric dental gel for dogs, designed to treat periodontal disease and support long-term oral health in companion animals. The innovative product utilizes a dual mechanism of action, where piezoelectric particles generate microcurrents to stimulate bone-forming cells and promote tissue regeneration. Developed in collaboration with a leading U.S. dental school, the product enhances Phibro’s companion animal healthcare portfolio and strengthens its position in advanced veterinary therapeutics, supporting expansion in high-growth animal health segments.

• In October 2024, Phibro Animal Health Corporation completed the acquisition of Zoetis Inc.’s medicated feed additive product portfolio along with certain water-soluble products. The acquisition includes more than 37 product lines across cattle, swine, and poultry, along with six manufacturing facilities located in the U.S., Italy, and China, and a workforce of over 300 employees. This strategic move strengthens Phibro’s global animal health portfolio, enhances its production and distribution capabilities across approximately 80 countries, and supports expansion in disease prevention and nutrition solutions within the anticoccidial drugs market.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
• Drug Class
• Animal Type
• End-User
• Regions Covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Competitive Landscape – Elanco Animal Health, Zoetis Inc., Huvepharma, Phibro Animal Health Corporation, Ceva Santé Animale, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Anticoccidial Drugs Market Segmentation

By Drug Class

• Ionophores
• Chemical Anticoccidials

By Animal Type

• Poultry
• Livestock
• Companion Animals

By End-User

• Commercial Poultry Farms
• Livestock Farms
• Veterinary Clinics & Hospitals
• Pet Owners (Companion segment)

Global Anticoccidial Drugs Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/anticoccidial-drugs-market